Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FABP4 | P15090 | 3/20 | 0.62 |
| ▸ | FABP5 | Q01469 | 3/20 | 0.62 |
| ▸ | MAOA | P21397 | 8/20 | 0.58 |
| ▸ | MAOB | P27338 | 8/20 | 0.58 |
| ▸ | GRIN1 | Q05586 | 6/20 | 0.58 |
| ▸ | GRIN2A | Q12879 | 6/20 | 0.58 |
| ▸ | GRIN2B | Q13224 | 6/20 | 0.58 |
| ▸ | MEN1 | O00255 | 1/20 | 0.58 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.58 |
| ▸ | HDAC1 | Q13547 | 3/20 | 0.57 |
| ▸ | HDAC6 | Q9UBN7 | 3/20 | 0.57 |
| ▸ | ACHE | P22303 | 3/20 | 0.56 |
| ▸ | FABP3 | P05413 | 1/20 | 0.53 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.52 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.52 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24398894 | 0.98 | FABP4 (0.61) | FABP4FABP5MAOAMAOBGRIN1 | |
| SCHEMBL3066514 | 0.98 | FABP4 (0.61) | FABP4FABP5MAOAMAOBGRIN1 | |
| SCHEMBL9502396 | 0.98 | FABP4 (0.61) | FABP4FABP5MAOAMAOBGRIN1 | |
| SCHEMBL3066305 | 0.98 | FABP4 (0.61) | FABP4FABP5MAOAMAOBGRIN1 | |
| SCHEMBL30622271 | 0.98 | FABP4 (0.61) | FABP4FABP5MAOAMAOBGRIN1 | |
| SCHEMBL8204008 | 0.94 | FABP4 (0.61) | FABP4FABP5MAOAMAOBGRIN1 | |
| SCHEMBL31739357 | 0.94 | FABP4 (0.61) | FABP4FABP5MAOAMAOBGRIN1 | |
| SCHEMBL4552481 | 0.89 | FABP4 (0.68) | FABP4FABP5MAOAMAOBGRIN1 | |
| SCHEMBL6338101 | 0.87 | MAOA (0.69) | FABP4FABP5MAOAMAOBGRIN1 | |
| SCHEMBL10063551 | 0.87 | MAOA (0.69) | FABP4FABP5MAOAMAOBGRIN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110003089-A | A kind of 3- methylol -9- substituted carbazole and preparation method thereof | 陕西科技大学 | 2019-07-12 | — | — | CN | disclosed |
| CN-105492939-A | Phase difference film, polarizing plate, and liquid crystal display device | KONICA MINOLTA INC | 2016-04-13 | — | — | CN | disclosed |
| US-8420231-B2 | Iridium phosphorescent dendrimer, method of preparing the same and electroluminescent device including the iridium phosphorescent dendrimer | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2013-04-16 | — | — | US | disclosed |
| US-8420231-B2 | Iridium phosphorescent dendrimer, method of preparing the same and electroluminescent device including the iridium phosphorescent dendrimer | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2013-04-16 | — | — | US | disclosed |
| US-8420231-B2 | Iridium phosphorescent dendrimer, method of preparing the same and electroluminescent device including the iridium phosphorescent dendrimer | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2013-04-16 | — | — | US | disclosed |
| US-20100084970-A1 | IRIDIUM PHOSPHORESCENT DENDRIMER, METHOD OF PREPARING THE SAME AND ELECTROLUMINESCENT DEVICE INCLUDING THE IRIDIUM PHOSPHORESCENT DENDRIMER | SAMSUNG ELECTRONICS CO., LTD (KR) | 2010-04-08 | — | — | US | disclosed |
| US-20100084970-A1 | IRIDIUM PHOSPHORESCENT DENDRIMER, METHOD OF PREPARING THE SAME AND ELECTROLUMINESCENT DEVICE INCLUDING THE IRIDIUM PHOSPHORESCENT DENDRIMER | SAMSUNG ELECTRONICS CO., LTD (KR) | 2010-04-08 | — | — | US | disclosed |
| US-20100084970-A1 | IRIDIUM PHOSPHORESCENT DENDRIMER, METHOD OF PREPARING THE SAME AND ELECTROLUMINESCENT DEVICE INCLUDING THE IRIDIUM PHOSPHORESCENT DENDRIMER | SAMSUNG ELECTRONICS CO., LTD (KR) | 2010-04-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100084970-A1 | IRIDIUM PHOSPHORESCENT DENDRIMER, METHOD OF PREPARING THE SAME AND ELECTROLUMINESCENT DEVICE INCLUDING THE IRIDIUM PHOSPHORESCENT DENDRIMER | DNM1, FIS1, DCUN1D1 | FABP4 4794/4885FABP5 2872/4885MAOA 4032/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.